Chevron Left
Retour à Drug Commercialization

Avis et commentaires pour l'étudiant pour Drug Commercialization par Université de Californie à San Diego

4.7
177 notes
32 avis

À propos du cours

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conducted after a new drug has been approved by the regulatory agencies and launched. In these studies, the new drug is prescribed in an everyday healthcare environ­ment using a much larger group of patients. This enables new treat­ment uses for the new drug to be developed, comparisons with other treatments for the same indication to be made, and determination of the clinical effectiveness of the new drug in a wider variety of patient types, and more rare side effects, if any, may be detected . Pre-marketing strategy should be instigated as early as Phase 1 clinical trials to ensure that the market's needs are incorporated into the new drug's overall develop­ment. Later phases when clinical results are presented at international medical conferences the marketing strategy is then refined in order to develop an awareness amongst the medical community who will be prescribing the new drug. In addition to the marketing strategy, pricing strategy and a tactical plan will be developed. Promotional material, and the sales force will be trained so that when the product is approved they can promote the drug to physician, pharmacist and nurses. This course is intended as part 3 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Meilleurs avis

JR

Jan 08, 2017

Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.

JT

Jan 15, 2018

LOVE THIS COURSE!!! Exactly what I was looking for, a good overview of commercialization strategy in biotech.

Filtrer par :

1 - 25 sur 33 Examens pour Drug Commercialization

par Aline M B M

Jun 02, 2019

Audio ruim

par YOGESH S D

May 21, 2019

bird eye view from discovery till commercialization excellent presentation I wish this could be updated as per current developments

par Napoleon V M

May 17, 2019

Excellent content, very useful and understandable. A lot of good information.

par Siddharth R

Feb 15, 2019

Apt and precise. Gives you a holistic understanding of the drug commercialization process.

par Sanjay K N

Feb 07, 2019

Very comprehensive 101 course, good for folks who are new to ways of working of pharma industry

par Julián G A

Feb 02, 2019

Great course with well prepared lecturers and content. It accomplishes the goal of giving a better understanding of the process of Drug Commercialization with specific examples

par Levan C

Jan 08, 2019

A very nice introduction to "Drug commercialization". Lectures are given by experts of the field with real-world examples.

par Bilal

Jan 07, 2019

Very informative and easy to understand.

par Sourav M

Nov 03, 2018

Thank you.

par Carrie S

Aug 17, 2018

This course desperately needs to be updated

par Jason C D A

Jul 09, 2018

Great course, the best among the trio if you're in the pharmaceutical market in some capacity. Gives you an understanding of how drugs and devices are conceived then sold to the market. A point for improvement would be the discussion or at least the mention of the wholesaler market (e.g. ABC, Mckesson, Cardinal) and their positioning on the whole pharmaceutical supply chain (as well as its European counterparts).

par Tatiane c r

Jun 16, 2018

This course is not well updated

par Vanja T F

Mar 14, 2018

Very interesting topic and discussion points and truly impressive choice of presenters.

Presentations are bit better than in two previous courses, but not much. Additionally, most of the data is totally outdated, which is really shame and unexpected for Coursera course done by well known university.

par Vincent L

Feb 19, 2018

It was alright, couldve given more examples and cases

par Elif

Feb 08, 2018

Great course with the introduction of all needed concepts to guide through business concepts of Pharma!

par Magdalena K

Jan 24, 2018

Good basic course covering most important topics in drug commercialization.

par Jack T

Jan 15, 2018

LOVE THIS COURSE!!! Exactly what I was looking for, a good overview of commercialization strategy in biotech.

par Atocha C S

Nov 29, 2017

Great!

par Muhammed T k

Oct 24, 2017

some lectures are not understand

but generally

thank you

par Md. j s

Sep 25, 2017

good

par Nassim R

Sep 20, 2017

onboarding to discover the US and EU market, very few examples on Pharmerging countries

par Matthew F

Sep 12, 2017

Interesting course with some interesting and relevant case studies. This is a great 101 course with stronger focus in certain areas of commercialization.

par Matthew M

Sep 07, 2017

Good introduction for those not in industry but quite easy for those who are

par Pedro M H V

Aug 27, 2017

It was really helpful as a peson with a backgound on biochemistry but so little knowledge in the commercial side of pharma. Definitely recommended.

par Kierstin L

Aug 24, 2017

Etouillie was great and his experience commentary made the course more interesting. His biosimilar section is highly pertinent to the US current situation with lawsuits flying every which way. I do wish more regulatory process steps were included. The start up success last section was not helpful. More just seemed like a quick review article one could read about an approved drug and the story of someone bragging about how lucky they were.